BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24694175)

  • 1. Synthetic calanolides with bactericidal activity against replicating and nonreplicating Mycobacterium tuberculosis.
    Zheng P; Somersan-Karakaya S; Lu S; Roberts J; Pingle M; Warrier T; Little D; Guo X; Brickner SJ; Nathan CF; Gold B; Liu G
    J Med Chem; 2014 May; 57(9):3755-72. PubMed ID: 24694175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified calanolides incorporated with furan-2-nitro mimics against Mycobacterium tuberculosis.
    Liu Z; Guo X; Liu G
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1297-300. PubMed ID: 25681226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.
    Xu ZQ; Barrow WW; Suling WJ; Westbrook L; Barrow E; Lin YM; Flavin MT
    Bioorg Med Chem; 2004 Mar; 12(5):1199-207. PubMed ID: 14980631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
    Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline.
    Darby CM; Nathan CF
    J Antimicrob Chemother; 2010 Jul; 65(7):1424-7. PubMed ID: 20435781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzimidazole-based compounds kill Mycobacterium tuberculosis.
    Gong Y; Somersan Karakaya S; Guo X; Zheng P; Gold B; Ma Y; Little D; Roberts J; Warrier T; Jiang X; Pingle M; Nathan CF; Liu G
    Eur J Med Chem; 2014 Mar; 75():336-53. PubMed ID: 24556148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. a potent and selective series for further drug development.
    Lilienkampf A; Pieroni M; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2010 Jan; 53(2):678-88. PubMed ID: 20000577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-hydrogen-8-methylquinolones active against replicating and non-replicating Mycobacterium tuberculosis.
    Tabarrini O; Sabatini S; Massari S; Pieroni M; Franzblau SG; Cecchetti V
    Chem Biol Drug Des; 2012 Nov; 80(5):781-6. PubMed ID: 22889240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allylic thiocyanates as a new class of antitubercular agents.
    Silveira GP; Ferreira M; Fernandes L; Moraski GC; Cho S; Hwang C; Franzblau SG; Sá MM
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6486-9. PubMed ID: 22967767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.
    Karabanovich G; Zemanová J; Smutný T; Székely R; Šarkan M; Centárová I; Vocat A; Pávková I; Čonka P; Němeček J; Stolaříková J; Vejsová M; Vávrová K; Klimešová V; Hrabálek A; Pávek P; Cole ST; Mikušová K; Roh J
    J Med Chem; 2016 Mar; 59(6):2362-80. PubMed ID: 26948407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,2,3,4,8,9,10,11-octahydrobenzo[j]phenanthridine-7,12-diones as new leads against Mycobacterium tuberculosis.
    Cappoen D; Claes P; Jacobs J; Anthonissen R; Mathys V; Verschaeve L; Huygen K; De Kimpe N
    J Med Chem; 2014 Apr; 57(7):2895-907. PubMed ID: 24611928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs.
    Braendvang M; Bakken V; Gundersen LL
    Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates.
    Mehta A; Srivastva G; Kachhwaha S; Sharma M; Kothari SL
    J Ethnopharmacol; 2013 Aug; 149(1):195-200. PubMed ID: 23816500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification, synthesis, and pharmacological evaluation of tetrahydroindazole based ligands as novel antituberculosis agents.
    Guo S; Song Y; Huang Q; Yuan H; Wan B; Wang Y; He R; Beconi MG; Franzblau SG; Kozikowski AP
    J Med Chem; 2010 Jan; 53(2):649-59. PubMed ID: 20000470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes.
    Pieroni M; Lilienkampf A; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Oct; 52(20):6287-96. PubMed ID: 19757815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of new sugar derivatives and evaluation of their antibacterial activities against Mycobacterium tuberculosis.
    Horita Y; Takii T; Chiba T; Kuroishi R; Maeda Y; Kurono Y; Inagaki E; Nishimura K; Yamamoto Y; Abe C; Mori M; Onozaki K
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6313-6. PubMed ID: 19828313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Derivatives of 3-isoxazolecarboxylic acid esters: a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis.
    Lilienkampf A; Pieroni M; Franzblau SG; Bishai WR; Kozikowski AP
    Curr Top Med Chem; 2012; 12(7):729-34. PubMed ID: 22283815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in-vitro antimycobacterial activity of amino-5-[(substituted) phenyl]-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolylmethanethione.
    Ali MA; Yar MS; Siddiqui AA; Husain A; Abdullah M
    Acta Pol Pharm; 2007; 64(5):435-9. PubMed ID: 18540164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.
    Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
    Bioorg Med Chem; 2008 Mar; 16(6):3408-18. PubMed ID: 18304818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.